P14-02. Social impact events in Phambili, the first phase 2B HIV vaccine trial in South Africa

Documenti analoghi

• P15-08. Did unblinding affect HIV risk behaviour and risk perception in the HVTN503/Phambili study?
  di: Gray, GE, et al.
  Pubblicazione: (2009)
• Self-reported Benefits of Study Participation in HVTN 503, “Phambili”
  di: Allen, Mary A., et al.
  Pubblicazione: (2014)
• Does participation in an HIV vaccine efficacy trial affect risk behaviour in South Africa?
  di: Gray, GE, et al.
  Pubblicazione: (2013)
• P14-07. Offering new prevention modalities in HIV vaccine trials: experience with male circumcision in the Phambili trial
  di: de Bruyn, G, et al.
  Pubblicazione: (2009)
• Safety and efficacy assessment of the HVTN 503/Phambili Study: A double-blind randomized placebo-controlled test-of-concept study of a Clade B-based HIV-1 vaccine in South Africa
  di: Gray, GE, et al.
  Pubblicazione: (2011)